These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1674394)

  • 1. Effects of a single oral administration of Epanolol on exercise tolerance in patients with stable effort angina pectoris.
    Vandenbosch H; Piessens J; De Geest H
    Acta Cardiol; 1991; 46(1):11-25. PubMed ID: 1674394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of beta blockade with (epanolol) and without (atenolol) intrinsic sympathomimetic activity in stable angina pectoris. The Visacor Study Group.
    Boberg J; Larsen FF; Pehrsson SK
    Clin Cardiol; 1992 Aug; 15(8):591-5. PubMed ID: 1354086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of epanolol versus metoprolol in angina pectoris: report from a Swedish multicentre study of exercise tolerance.
    Rydén L
    J Intern Med; 1992 Jan; 231(1):7-11. PubMed ID: 1346268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of epanolol and diltiazem on exercise performance and respiratory gas exchange in angina pectoris.
    Riley M; Elborn JS; Khan MM; Stanford CF; Nicholls DP
    Eur Heart J; 1992 Aug; 13(8):1116-22. PubMed ID: 1354616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of two doses of bisoprolol on exercise tolerance in exercise-induced stable angina pectoris.
    de Muinck E; Wagner G; vd Ven LL; Lie KI
    Eur Heart J; 1987 Dec; 8 Suppl M():31-5. PubMed ID: 2897300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epanolol. A new once-daily antianginal agent: dose finding and long term efficacy.
    Akhras F; Jackson G
    Drugs; 1989; 38 Suppl 2():28-34. PubMed ID: 2575977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of epanolol and metoprolol on the heart measured by 24-hour holter monitoring.
    Withagen AJ; Corbeij HM; Huige MC; Kragten JA; Vermeulen A
    Drugs; 1989; 38 Suppl 2():67-9. PubMed ID: 2575985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose finding in angina--results with epanolol.
    Omland TM; von Brandis C; Abrahamsen AM
    Drugs; 1989; 38 Suppl 2():35-8. PubMed ID: 2575978
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of beta-adrenoceptor blockade on atrial natriuretic peptide levels during exercise in angina pectoris.
    Riley M; Elborn JS; Onuoha G; Erwin C; Shaw C; Khan MM; Stanford CF; Nicholls DP
    Br J Clin Pharmacol; 1993 Feb; 35(2):209-12. PubMed ID: 8095150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of epanolol (ICI 141,292) in healthy young volunteers and comparative data in elderly patients with angina and subjects with renal or hepatic impairment.
    Cockshott ID
    Drugs; 1989; 38 Suppl 2():10-7. PubMed ID: 2575975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modest antihypertensive effect of epanolol, a beta 1-selective receptor blocker with beta 1 agonist activity: an acute and long-term hemodynamic study at rest and during exercise and double crossover comparison with atenolol on ambulatory blood pressure.
    Omvik P; Lund-Johansen P; Haugland H
    Cardiovasc Drugs Ther; 1993 Feb; 7(1):125-32. PubMed ID: 8097925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of epanolol and nifedipine in stable angina patients: results of a multicentre trial.
    Blake P; Berry SC; Readman A; Ratcliffe M; Godley M
    Cardiology; 1991; 79(4):249-55. PubMed ID: 1685942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new water-soluble, selective beta-blocker with intrinsic sympathomimetic activity (ICI 141.292) in angina pectoris.
    Erikssen J; Rollag A; Otterstad JE
    Acta Med Scand; 1988; 223(1):35-43. PubMed ID: 2894747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of epanolol in elderly patients with stable angina pectoris.
    Marlier R; McAinsh J; Cockshott ID
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):142-4. PubMed ID: 1970734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of possible pharmacokinetic and pharmacodynamic interactions between epanolol and digoxin.
    Lefebvre RA; Bogaert MG; Duprez D
    Eur J Clin Pharmacol; 1990; 38(5):505-7. PubMed ID: 1974206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-anginal and anti-ischemic effects of the selective beta-blocker talinolol in patients with stable angina pectoris.
    Faulhaber HD; Weigmann I; Lang U; Weinsberg F; Terhaag B
    Int J Clin Pharmacol Ther; 2005 Feb; 43(2):63-70. PubMed ID: 15726874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of epanolol, a selective beta1-blocker with intrinsic sympathomimetic activity, in patients with ischemic left ventricular dysfunction.
    Van Den Heuvel AF; van der Ent M; van Veldhuisen DJ; Kruijssen DA; Bartels GL; Remme WJ
    J Cardiovasc Pharmacol; 1998 Apr; 31(4):506-12. PubMed ID: 9554797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Slow-release metoprolol in angina pectoris. A comparative study of a cardioselective beta-blocking drug, metoprolol, in ordinary and slow-release tablets (Durules) in the treatment of angina pectoris.
    Uusitalo AJ; Keyriläinen O
    Ann Clin Res; 1979 Oct; 11(5):199-204. PubMed ID: 44671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative multicentre study of the tolerability and efficacy of epanolol versus nifedipine in patients with stable angina pectoris.
    Readman AS
    Drugs; 1989; 38 Suppl 2():61-5. PubMed ID: 2575983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of epanolol after acute and chronic oral dosing in elderly patients with stable angina pectoris.
    Hosie J; Scott AK; Petrie JC; Cockshott ID
    Br J Clin Pharmacol; 1990 Mar; 29(3):333-7. PubMed ID: 1968755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.